In addition to ongoing research into feline mammary tumors at Cornell, researchers across North America are evaluating potential diagnostic and treatment options for cats with the disease. Ongoing studies include:
– Researchers at University of Guelph’s Ontario Veterinary College and McMaster University’s Immunology Research Centre launched a clinical trial last fall to test the effectiveness of new vaccines in treating mammary gland cancer in cats. The vaccines, designed to stimulate a cat’s immune system and kill tumor cells without harming healthy tissue, could be a groundbreaking step in treatment.
– Researchers at the University of Pennsylvania School of Veterinary Medicine are testing two human cancer drugs on cats with mammary cancer in hopes that they might decrease rates of tumor recurrence and metastasis, and increase survival time.
– A researcher at the North Carolina State University College of Veterinary Medicine is seeking to categorize the subtypes of feline mammary tumors based on abnormalities in their DNA in hopes of better predicting how tumors are likely to progress.
